IRIS Accounts Production v23.3.0.418 11176116 Board of Directors 1.4.22 31.3.23 31.3.23 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh111761162022-03-31111761162023-03-31111761162022-04-012023-03-31111761162021-03-31111761162021-04-012022-03-31111761162022-03-3111176116ns10:Originalns15:EnglandWales2022-04-012023-03-3111176116ns14:PoundSterlingns10:Original2022-04-012023-03-3111176116ns10:Originalns10:Director12022-04-012023-03-3111176116ns10:Original2022-04-012023-03-3111176116ns10:Original2023-03-3111176116ns10:Originalns10:PrivateLimitedCompanyLtd2022-04-012023-03-3111176116ns10:Originalns10:SmallEntities2022-04-012023-03-3111176116ns10:Originalns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3111176116ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3111176116ns10:SmallCompaniesRegimeForAccountsns10:Original2022-04-012023-03-3111176116ns10:Originalns10:AbridgedAccounts2022-04-012023-03-3111176116ns10:Original12022-04-012023-03-3111176116ns10:Originalns10:Director22022-04-012023-03-3111176116ns10:Originalns10:RegisteredOffice2022-04-012023-03-3111176116ns10:Original2022-03-3111176116ns10:Originalns5:CurrentFinancialInstruments2023-03-3111176116ns10:Originalns5:CurrentFinancialInstruments2022-03-3111176116ns5:ShareCapitalns10:Original2023-03-3111176116ns5:ShareCapitalns10:Original2022-03-3111176116ns10:Originalns5:RevaluationReserve2023-03-3111176116ns10:Originalns5:RevaluationReserve2022-03-3111176116ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-03-3111176116ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-03-3111176116ns10:Originalns5:NetGoodwill2022-04-012023-03-3111176116ns5:IntangibleAssetsOtherThanGoodwillns10:Original2022-04-012023-03-3111176116ns10:Originalns5:OwnedOrFreeholdAssetsns5:LandBuildings2022-04-012023-03-3111176116ns10:Originalns5:PlantMachinery2022-04-012023-03-3111176116ns10:Originalns5:FurnitureFittings2022-04-012023-03-3111176116ns10:Originalns5:MotorVehicles2022-04-012023-03-3111176116ns10:Original2021-04-012022-03-3111176116ns10:Original2022-03-31
REGISTERED NUMBER: 11176116 (England and Wales)

































Unaudited Financial Statements

For The Year Ended

31 March 2023

for

WINDWARD HEALTH LTD

WINDWARD HEALTH LTD (REGISTERED NUMBER: 11176116)






Contents of the Financial Statements
For The Year Ended 31 March 2023




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 3


WINDWARD HEALTH LTD

Company Information
For The Year Ended 31 March 2023







DIRECTORS: Mr P F Murphy
Mrs L E Murphy





REGISTERED OFFICE: 13 Station Approach
Meols
Wirral
Merseyside
CH47 8XA





REGISTERED NUMBER: 11176116 (England and Wales)





ACCOUNTANTS: Leavitt Walmsley Associates Limited
Chartered Certified Accountants
8 Eastway
Sale
Cheshire
M33 4DX

WINDWARD HEALTH LTD (REGISTERED NUMBER: 11176116)

Abridged Balance Sheet
31 March 2023

31.3.23 31.3.22
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 669,221 713,836
Tangible assets 5 321,809 269,864
991,030 983,700

CURRENT ASSETS
Stocks 72,566 51,838
Debtors 205,423 251,398
Cash at bank and in hand 116,311 92,837
394,300 396,073
CREDITORS
Amounts falling due within one year 1,134,719 1,260,077
NET CURRENT LIABILITIES (740,419 ) (864,004 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

250,611

119,696

PROVISIONS FOR LIABILITIES 16,716 5,761
NET ASSETS 233,895 113,935

CAPITAL AND RESERVES
Called up share capital 100 100
Revaluation reserve 6 52,650 -
Retained earnings 181,145 113,835
SHAREHOLDERS' FUNDS 233,895 113,935

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 31 March 2023 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 20 October 2023 and were signed on its behalf by:



Mr P F Murphy - Director


WINDWARD HEALTH LTD (REGISTERED NUMBER: 11176116)

Notes to the Financial Statements
For The Year Ended 31 March 2023

1. STATUTORY INFORMATION

Windward Health Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of FRS 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover represents sales of goods excluding Value Added Tax made during the year and derives from the provision of goods falling within the company's ordinary activities. Prescription income is recognised in the accounts on an arising basis on confirmation from the Prescription Pricing Department whilst counter sales are recognised as income on payment by the customer.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2018, is being amortised evenly over its estimated useful life of twenty years.

Goodwill, being the amount paid in connection with the acquisition of a business in 2018, is being amortised evenly over its estimated useful life of twenty years. Goodwill is measured at costs less amortisation less accumulated impairment.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Freehold property - 2% on cost
Plant and machinery - 33% on cost
Fixtures and fittings - 20% on cost
Motor vehicles - 25% on reducing balance

Tangible fixed assets are stated at cost less accumulated depreciation and accumulated impairment losses. Cost includes costs which are directly attributable in bringing the asset to its location and condition so that it is capable of operating in the manner intended by management.

Profits and losses on the disposal of fixed assets are included in the calculation of profit for the year.

The directors assess the company's tangible assets for evidence of impairment at each reporting date. Where there are indicators of impairment, the directors calculate recoverable amount of the asset(s) and compare this with the carrying amount. If recoverable amount is lower than carrying amount, the asset is written down to recoverable amount by way of an impairment loss which is recognised in profit or loss for the year. Impairment losses are reversed when there is evidence that the reasons giving rise to the original impairment loss have ceased to apply. Impairment losses are reversed through profit and loss, but only to the extent that the reversal does not increase the carrying amount of the asset to the amount which would have been stated, net of depreciation, had no impairment loss been recognised.

WINDWARD HEALTH LTD (REGISTERED NUMBER: 11176116)

Notes to the Financial Statements - continued
For The Year Ended 31 March 2023

2. ACCOUNTING POLICIES - continued

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Stocks and work in progress are valued at the lower of cost and estimated selling price less costs to complete and sell, after making due allowance for obsolete and slow moving items.

Cost is calculated using the first-in, first-out method and includes all purchase, transport, and handling costs in bringing stocks to their present location and condition.

Estimated selling price is the price which would be obtained by selling the product in the open market in an arm's length transaction.

Provision is made by way of write down to estimated selling price less costs to complete and sell for obsolete and slow moving items.

Financial instruments
A financial asset or financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument.

Basic financial instruments are initially recognised at transaction price and measured at amortised cost using the effective interest method. Where investments in non-derivative financial instruments are publicly traded, or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value through profit or loss. All other investments are subsequently measured at cost less impairment.

Debtors and creditors which fall due within one year are recorded in the financial statements at transaction price and subsequently measured at amortised cost. If the effects of the time value of money are immaterial, they are measured at cost (less impairment for trade debtors). Debtors are reviewed for impairment at each reporting date and any impairments are recorded in profit or loss and shown within administrative expenses when there is objective evidence that a debtor is impaired. Objective evidence that a debtor is impaired arises when the customer is unable to settle amounts owing to the company or the customer becomes bankrupt.

Debtors do not carry interest and are stated at their nominal value.

Trade creditors are not interest-bearing and are stated at their nominal value.

Financial assets which are measured at cost or amortised cost are reviewed for objective evidence of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. All equity instruments, regardless of significance, and other financial assets that are individually significant, are assessed individually for impairment. Other financial assets are either assessed individually or grouped on the basis of similar credit risk characteristics.

Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset which exceeds what the carrying amount would have been had the impairment loss not previously been recognised.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and loss account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Employee benefits
Short-term employee benefits are measured at the undiscounted amount expected to be paid in exchange for the employee's services to the company. Where employees have accrued short-term benefits which the entity has not paid by the balance sheet date, an accrual is recognised within creditors: amounts falling due within one year with an associated expense in profit or loss.

WINDWARD HEALTH LTD (REGISTERED NUMBER: 11176116)

Notes to the Financial Statements - continued
For The Year Ended 31 March 2023

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 16 (2022 - 15 ) .

4. INTANGIBLE FIXED ASSETS
Totals
£   
COST
At 1 April 2022
and 31 March 2023 892,295
AMORTISATION
At 1 April 2022 178,459
Amortisation for year 44,615
At 31 March 2023 223,074
NET BOOK VALUE

At 31 March 2023 669,221
At 31 March 2022 713,836

5. TANGIBLE FIXED ASSETS
Totals
£   
COST OR VALUATION
At 1 April 2022 305,110
Additions 141
Revaluations 65,000
At 31 March 2023 370,251
DEPRECIATION
At 1 April 2022 35,246
Charge for year 13,196
At 31 March 2023 48,442
NET BOOK VALUE
At 31 March 2023 321,809
At 31 March 2022 269,864

Cost or valuation at 31 March 2023 is represented by:

Totals
£   
Valuation in 2023 328,996
Cost 41,255
370,251

6. RESERVES
Revaluation
reserve
£   
Transfers 52,650

At 31 March 2023 52,650